SAN MATEO, Calif., Sept. 9 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that Joshua Kazam, Chief Executive Officer, will present at the Rodman & Renshaw 12th Annual Global Investment Conference on Tuesday, September 14, 2010 at 2:00 p.m. (Eastern Time) at the Palace Hotel in New York City, New York.
